Drug Patents owned by Sanofi

1. List of Renvela drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7985418 SANOFI Aliphatic amine polymer salts for tableting
Oct, 2025

(2 years from now)

Drugs and Companies using SEVELAMER CARBONATE ingredient

Market Authorisation Date: 19 October, 2007

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of RENVELA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic